טוען...
Potential synergistic effect of phosphodiesterase inhibitors with chemotherapy in lung cancer
Purpose: Lung cancer remains the leading cause of cancer-related deaths worldwide and novel therapeutic approaches targeting crucial pathways are urgently needed to improve its treatment. Differentiation-based therapeutics (Methylxanthines) and phosphodiesterase inhibitors (type 4 and 5), have been...
שמור ב:
| הוצא לאור ב: | J Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Ivyspring International Publisher
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5688917/ https://ncbi.nlm.nih.gov/pubmed/29151951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.21783 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|